Tandem Diabetes Care, Inc. (TNDM) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TNDM Revenue Growth
Revenue Breakdown (FY 2025)
TNDM's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
TNDM Revenue Analysis (2014–2025)
As of May 7, 2026, Tandem Diabetes Care, Inc. (TNDM) generated trailing twelve-month (TTM) revenue of $1.01 billion, reflecting modest growth of +2.7% year-over-year. The most recent quarter (Q4 2025) recorded $290.4 million in revenue, up 16.5% sequentially.
Looking at the longer-term picture, TNDM's 5-year compound annual growth rate (CAGR) stands at +15.3%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $1.01 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows TNDM's business is primarily driven by Supplies and Other (54%), and Pump (46%). With over half of revenue concentrated in Supplies and Other, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including PODD (+31.9% YoY), DXCM (+16.2% YoY), and ABBV (+8.6% YoY), TNDM has underperformed the peer group in terms of revenue growth. Compare TNDM vs PODD →
TNDM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TNDMCurrent | $1.0B | +2.7% | +15.3% | -7.7% | |
 PODD | $2.7B | +31.9% | +24.5% | 17.5% | |
 DXCM | $4.7B | +16.2% | +19.3% | 19.6% | |
 ABBV | $61.2B | +8.6% | +6.0% | 32.8% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 NVO | $309.1B | +6.4% | +19.5% | 41.3% |
TNDM Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.01B | +7.9% | $530.8M | 52.3% | $-78,122,000 | -7.7% |
| 2024 | $940.2M | +25.7% | $489.6M | 52.1% | $-99,127,000 | -10.5% |
| 2023 | $747.7M | -6.7% | $367.7M | 49.2% | $-233,230,000 | -31.2% |
| 2022 | $801.2M | +14.0% | $413.0M | 51.5% | $-92,848,000 | -11.6% |
| 2021 | $702.8M | +40.9% | $376.2M | 53.5% | $22.7M | 3.2% |
| 2020 | $498.8M | +37.7% | $260.5M | 52.2% | $-7,957,000 | -1.6% |
| 2019 | $362.3M | +97.0% | $194.2M | 53.6% | $-16,722,000 | -4.6% |
| 2018 | $183.9M | +70.9% | $89.8M | 48.9% | $-44,631,000 | -24.3% |
| 2017 | $107.6M | +27.7% | $44.1M | 41.0% | $-62,944,000 | -58.5% |
| 2016 | $84.2M | +15.6% | $23.6M | 28.0% | $-78,051,000 | -92.6% |
See TNDM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TNDM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TNDM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTNDM — Frequently Asked Questions
Quick answers to the most common questions about buying TNDM stock.
Is TNDM's revenue growth accelerating or slowing?
TNDM revenue growth slowed to +2.7%, below the 5-year CAGR of +15.3%. TTM revenue is $1.0B. The deceleration marks a shift from historical growth rates.
What is TNDM's long-term revenue growth rate?
Tandem Diabetes Care, Inc.'s 5-year revenue CAGR of +15.3% reflects the variable expansion pattern. Current YoY growth of +2.7% is near this long-term average.
How is TNDM's revenue distributed by segment?
TNDM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.